litlas
Log inCreate account

Klaus Lechner

Active 1979–2012

97
Papers
20,656
Citations
84
h-index
97
i10-index

Citations

Citations per year for Klaus Lechner1976: 1 citations1978: 1 citations1979: 2 citations1980: 1 citations1981: 3 citations1982: 4 citations1983: 10 citations1984: 6 citations1985: 11 citations1986: 15 citations1987: 17 citations1988: 21 citations1989: 35 citations1990: 25 citations1991: 27 citations1992: 52 citations1993: 50 citations1994: 59 citations1995: 53 citations1996: 66 citations1997: 56 citations1998: 87 citations1999: 109 citations2000: 102 citations2001: 137 citations2002: 157 citations2003: 199 citations2004: 163 citations2005: 168 citations2006: 176 citations2007: 181 citations2008: 151 citations2009: 154 citations2010: 126 citations2011: 121 citations2012: 106 citations2013: 84 citations2014: 82 citations2015: 86 citations2016: 80 citations2017: 81 citations2018: 69 citations2019: 261 citations2020: 218 citations2021: 226 citations2022: 147 citations2023: 86 citations2024: 140 citations2025: 57 citations1977: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,528 citing papers, 26.1% of this breakdownUnited Kingdom: 462 citing papers, 7.9% of this breakdownGermany: 422 citing papers, 7.2% of this breakdownItaly: 418 citing papers, 7.2% of this breakdownFrance: 361 citing papers, 6.2% of this breakdownAustria: 315 citing papers, 5.4% of this breakdownCanada: 232 citing papers, 4% of this breakdownNetherlands: 228 citing papers, 3.9% of this breakdownChina: 210 citing papers, 3.6% of this breakdownSpain: 183 citing papers, 3.1% of this breakdownSwitzerland: 166 citing papers, 2.8% of this breakdownAustralia: 156 citing papers, 2.7% of this breakdown
0%26.1%Other 19.9%

Institutions

Fields

  • Medicine78.4%
  • Immunology and Microbiology13.5%
  • Biochemistry, Genetics and Molecular Biology6.5%
  • Materials Science0.2%
  • Computer Science0.2%
  • Pharmacology, Toxicology and Pharmaceutics0.2%
  • Other1%

Topics

  • Platelet Disorders and Treatments6.6%
  • Chronic Myeloid Leukemia Treatments5.8%
  • Blood Coagulation and Thrombosis Mechanisms4.5%
  • Chronic Lymphocytic Leukemia Research4.4%
  • Blood groups and transfusion4.3%
  • Mast cells and histamine3.9%
  • Other70.5%

Coauthors

All papers

Open in search
  1. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

    Authors: Francesco Rodeghiero, Roberto Stasi, Terry Gernsheimer, Marc Michel, Drew Provan, Donald M. Arnold, James B. Bussel, Douglas B. Cines, Beng H. Chong, Nichola Cooper, Bertrand Godeau, Klaus Lechner, Maria Gabriella Mazzucconi, Robert McMillan, Miguel Á. Sanz, Paul Imbach, Victor S. Blanchette, Thomas Kühne, Marco Ruggeri, James N. George - Blood 2008 cited by 2,660

  2. Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

    Authors: Stephen G. O’Brien, François Guilhot, Richard A. Larson, Insa Gathmann, Michele Baccarani, Francisco Cervantes, Jan J. Cornelissen, Thomas Fischer, Andreas Hochhaus, Timothy P. Hughes, Klaus Lechner, Johan Lanng Nielsen, Philippe Rousselot, Josy Reiffers, Giuseppe Saglio, John D. Shepherd, Bengt Simonsson, Aloïs Gratwohl, John M. Goldman, Hagop M. Kantarjian, Kerry Taylor, Gregor Verhoef, Ann E. Bolton, Renaud Capdeville, Brian Druker - New England Journal of Medicine 2003 cited by 3,565

  3. High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism

    Authors: Paul A. Kyrle, Erich Minar, Mirko Hirschl, Christine Bialonczyk, Milena Stain, Barbara Schneider, Ansgar Weltermann, Wolfgang Speiser, Klaus Lechner, Sabine Eichinger - New England Journal of Medicine 2000 cited by 764

  4. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture

    Authors: Peter Valent, E Spanblöchl, Wolfgang R. Sperr, Christian Sillaber, KM Zsebo, Hermine Agis, Herbert Strobl, Klaus Geißler, Peter Bettelheim, Klaus Lechner - Blood 1992 cited by 445

  5. Cancer-Related Microangiopathic Hemolytic Anemia

    Authors: Klaus Lechner, Hanna Lena Obermeier - Medicine 2012 cited by 224

  6. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells

    Authors: Wolfgang Füreder, Hermine Agis, Martin Willheim, Hans Bankl, Uwe‐G. Maier, Kenji Kishi, M.R Müller, K. Czerwenka, T Radaszkiewicz, J.H. Butterfield, G Klappacher, Wolfgang R. Sperr, Martin Oppermann, Klaus Lechner, Peter Valent - The Journal of Immunology 1995 cited by 190

  7. Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia

    Authors: Wolfgang R. Sperr, John-Hendrik Jordan, Mehrdad Baghestanian, Hans-Peter Kiener, Puchit Samorapoompichit, H. Semper, Alexander W. Hauswirth, G. Schernthaner, Andreas Chott, Susanne Natter, Dietrich Kraft, Rudolf Valenta, Lawrence B. Schwartz, Klaus Geißler, Klaus Lechner, Peter Valent - Blood 2001 cited by 148

  8. A Survey of 215 Non-Hemophilic Patients with Inhibitors to Factor VIII

    Authors: David Green, Klaus Lechner - Thrombosis and Haemostasis 1981 cited by 787

  9. 1,25-Dihydroxyvitamin D3 inhibits dendritic cell differentiation and maturation in vitro

    Authors: A. Berer, Johannes Stöckl, Otto Majdic, Thomas Wagner, Marietta Kollars, Klaus Lechner, Klaus Geißler, Leopold Oehler - Experimental Hematology 2000 cited by 221

  10. Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism

    Authors: Ingrid Pabinger, Helga Grafenhofer, Paul A. Kyrle, Peter Quehenberger, Christine Mannhalter, Klaus Lechner, Alexandra Kaider - Blood 2002 cited by 210

  11. Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis

    Authors: Sophie Ziegler, Wolfgang R. Sperr, Paul Knöbl, Stephan Lehr, Ansgar Weltermann, Ulrich Jäger, Peter Valent, Klaus Lechner - Thrombosis Research 2004 cited by 113

  12. Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES)

    Authors: Brigitte Habermalz, Stefan Sauerland, G. Anton Decker, B Delaître, J. F. Gigot, Emmanuel Leandros, Klaus Lechner, M Rhodes, Gianfranço Silecchia, Amir Szold, Eduardo M. Targarona, P Torelli, Edmund Neugebauer - Surgical Endoscopy 2008 cited by 298

  13. Risk of pregnancy‐associated recurrent venous thromboembolism in women with a history of venous thrombosis

    Authors: Ingrid Pabinger, Helga Grafenhofer, Alexandra Kaider, Paul A. Kyrle, Peter Quehenberger, Christine Mannhalter, Klaus Lechner - Journal of Thrombosis and Haemostasis 2005 cited by 224

  14. Serum Tryptase Measurements in Patients with Myelodysplastic Syndromes

    Authors: Wolfgang R. Sperr, Birgitta Stehberger, Friedrich Wimazal, Mehrdad Baghestanian, Lawrence B. Schwartz, Michael Kundi, H. Semper, J-H. Jordan, Andreas Chott, Johannes Drach, Ulrich Jäger, Klaus Geißler, A Greschniok, Horny Hp, Klaus Lechner, Peter Valent - Leukemia & lymphoma/Leukemia and lymphoma 2002 cited by 84

  15. Glycosylated hemoglobins (GHb): an index of red cell survival

    Authors: Simon Panzer, G Kronik, Klaus Lechner, Peter Bettelheim, E Neumann, Robert Dudczak - Blood 1982 cited by 190

  16. Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression

    Authors: Alexander Gaiger, Traudl Henn, E Hörth, Klaus Geißler, Gerlinde Mitterbauer, Theresia Maier-Dobersberger, Hildegard Greinix, Christine Mannhalter, OA Haas, Klaus Lechner - Blood 1995 cited by 163

  17. Paraneoplastic autoimmune thrombocytopenia in solid tumors

    Authors: Maria‐Theresa Krauth, Joe Puthenparambil, Klaus Lechner - Critical Reviews in Oncology/Hematology 2011 cited by 85

  18. The Immunophenotype of 325 Adult Acute Leukemias

    Authors: Renate Thalhammer-Scherrer, Gerlinde Mitterbauer, Ingrid Simonitsch, Ulrich Jaeger, Klaus Lechner, Barbara Schneider, Christa Fonatsch, Ilse Schwarzinger - American Journal of Clinical Pathology 2002 cited by 83

  19. How I treat autoimmune hemolytic anemias in adults

    Authors: Klaus Lechner, Ulrich Jäger - Blood 2010 cited by 332

  20. A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia

    Authors: Gerhard Heil, Dieter Hoelzer, Miguel Á. Sanz, Klaus Lechner, John A. Liu Yin, Giuseppe Francesco Sferrazza Papa, L. Noens, Jeff Szer, Arnold Ganser, Caroline O’Brien, James Matcham, Alan Barge - Blood 1997 cited by 332

  21. Interleukin-3 is a differentiation factor for human basophils

    Authors: Peter Valent, G. Schmidt, J Besemer, P. Mayer, Gerhard Zenke, E. Liehl, W Hinterberger, Klaus Lechner, Dieter Maurer, Peter Bettelheim - Blood 1989 cited by 215

  22. The Risk of Recurrent Venous Thromboembolism in Patients with and without Factor V Leiden

    Authors: Sabine Eichinger, Ingrid Pabinger, Andreas Stümpfien, Mirko Hirschl, Christine Bialonczyk, Barbara Schneider, Christine Mannhalter, Erich Minar, Klaus Lechner, Paul A. Kyrle - Thrombosis and Haemostasis 1997 cited by 206

  23. Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes

    Authors: Peter Valent, LK Ashman, W Hinterberger, F. Eckersberger, Otto Majdic, Klaus Lechner, Peter Bettelheim - Blood 1989 cited by 206

  24. Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes

    Authors: Hermine Agis, Wolfgang Füreder, Hans Bankl, Michael Kundi, Wolfgang R. Sperr, Martin Willheim, G Boltz-Nitulescu, Joseph H. Butterfield, Kenji Kishi, Klaus Lechner, Peter Valent - Immunology 1996 cited by 142